COVID-19 in Patients with Classic and Variant Hairy Cell Leukemia.

Robert J. Kreitman, Theresa Yu,Lacey James,Julie Feurtado, Holly Eager,Olena Sierra Ortiz,Mory Gould,Jack Mauter,Hong Zhou,Peter D. Burbelo,Jeffrey I. Cohen,Hao-Wei Wang,Constance M. Yuan,Evgeny Arons

Deleted Journal（2024）

Cited 1|Views24

Key words

COVID-19,vaccine,hairy cell leukemia,variant,cladribine,rituximab,vemurafenib,dabrafenib,trametinib,encorafenib,binimetinib,moxetumomab pasudotox,minimal residual disease

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined